Mirikizumab (Anti-IL-23)
Mirikizumab (Anti-IL-23) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23. Mirikizumab can be used for research on ulcerative colitis. MW: 144.26 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2967 |
| Sku # | A2967-1mg*25 |
| Pricing | 1mg*25, $2970.00 |